Bio-Rad Laboratories Company
Bio-Rad Laboratories offers a range of diagnostic solutions for Lyme disease, including advanced serological tests that provide accurate detection of Borrelia infection. Their cutting-edge technologies support early and reliable diagnosis, aiding in the effective management of Lyme disease.
Estimated Revenue:
$500M to $1B
Funding Status:
IPO
Employee Number:
5001-10000
Industry:
PharmTech
Headquarters:
USA
Founded Date:
1952
Technology:
Drug Delivery